Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koichiro Akakura

Showing results (81-90 of 118) with videos related to

Pageof 12
Sort By:
Current Oncology (Toronto, Ont.)|October 27, 2023
Identification of Early Biochemical Recurrence Predictors in High-Risk Prostate Cancer Patients Treated with Carbon-Ion Radiotherapy and Androgen Deprivation TherapyTakanobu Utsumi, Hiroyoshi Suzuki, Hitoshi Ishikawa, et al.
Anticancer Research|December 13, 2005
Interleukin-4 in patients with prostate cancerUeda Takeshi, Marianne D Sadar, Hiroyoshi Suzuki, et al.
European Urology|May 10, 2002
Correlation of initial PSA level and biopsy features with PSA-doubling time in early stage prostate cancers in Japanese menYoshiyuki Kakehi, Toshiyuki Kamoto, Taizo Shiraishi, et al.
International Journal of Radiation Oncology, Biology, Physics|May 6, 2008
Adverse effects of androgen deprivation therapy on persistent genitourinary complications after carbon ion radiotherapy for prostate cancerHitoshi Ishikawa, Hiroshi Tsuji, Tadashi Kamada, et al.
Japanese Journal of Cancer Research : Gann|April 3, 2002
Expression of thymidine phosphorylase in primary human renal cell carcinoma by ELISA methodHidetoshi Kinsui, Takeshi Ueda, Hiroyoshi Suzuki, et al.
Prostate International|December 1, 2017
Significant prognostic difference between Grade Group 4 and 5 in the 2014 International Society of Urological Pathology Grading System for High Grade Prostate Cancer with Bone MetastasisYasutaka Yamada, Shinichi Sakamoto, Jun Shimazaki, et al.
The Prostate|December 10, 2019
Higher serum testosterone levels predict poor prognosis in castration-resistant prostate cancer patients treated with docetaxelKeisuke Ando, Shinichi Sakamoto, Nobushige Takeshita, et al.
Prostate International|January 21, 2022
Revision of CHAARTED and LATITUDE criteria among Japanese de novo metastatic prostate cancer patientsManato Kanesaka, Shinichi Sakamoto, Yasutaka Yamada, et al.
Cancer|June 29, 2016
Significant impact of biochemical recurrence on overall mortality in patients with high-risk prostate cancer after carbon-ion radiotherapy combined with androgen deprivation therapyGoro Kasuya, Hitoshi Ishikawa, Hiroshi Tsuji, et al.
The Journal of Urology|April 12, 2015
Nadir Testosterone after Long-Term Followup Predicts Prognosis in Patients with Prostate Cancer Treated with Combined Androgen BlockadeShuhei Kamada, Shinichi Sakamoto, Keisuke Ando, et al.
Pageof 12

Showing results (81-90 of 118) with videos related to

Sort By:
Pageof 12
Current Oncology (Toronto, Ont.)|October 27, 2023
Identification of Early Biochemical Recurrence Predictors in High-Risk Prostate Cancer Patients Treated with Carbon-Ion Radiotherapy and Androgen Deprivation TherapyTakanobu Utsumi, Hiroyoshi Suzuki, Hitoshi Ishikawa, et al.
Anticancer Research|December 13, 2005
Interleukin-4 in patients with prostate cancerUeda Takeshi, Marianne D Sadar, Hiroyoshi Suzuki, et al.
European Urology|May 10, 2002
Correlation of initial PSA level and biopsy features with PSA-doubling time in early stage prostate cancers in Japanese menYoshiyuki Kakehi, Toshiyuki Kamoto, Taizo Shiraishi, et al.
International Journal of Radiation Oncology, Biology, Physics|May 6, 2008
Adverse effects of androgen deprivation therapy on persistent genitourinary complications after carbon ion radiotherapy for prostate cancerHitoshi Ishikawa, Hiroshi Tsuji, Tadashi Kamada, et al.
Japanese Journal of Cancer Research : Gann|April 3, 2002
Expression of thymidine phosphorylase in primary human renal cell carcinoma by ELISA methodHidetoshi Kinsui, Takeshi Ueda, Hiroyoshi Suzuki, et al.
Prostate International|December 1, 2017
Significant prognostic difference between Grade Group 4 and 5 in the 2014 International Society of Urological Pathology Grading System for High Grade Prostate Cancer with Bone MetastasisYasutaka Yamada, Shinichi Sakamoto, Jun Shimazaki, et al.
The Prostate|December 10, 2019
Higher serum testosterone levels predict poor prognosis in castration-resistant prostate cancer patients treated with docetaxelKeisuke Ando, Shinichi Sakamoto, Nobushige Takeshita, et al.
Prostate International|January 21, 2022
Revision of CHAARTED and LATITUDE criteria among Japanese de novo metastatic prostate cancer patientsManato Kanesaka, Shinichi Sakamoto, Yasutaka Yamada, et al.
Cancer|June 29, 2016
Significant impact of biochemical recurrence on overall mortality in patients with high-risk prostate cancer after carbon-ion radiotherapy combined with androgen deprivation therapyGoro Kasuya, Hitoshi Ishikawa, Hiroshi Tsuji, et al.
The Journal of Urology|April 12, 2015
Nadir Testosterone after Long-Term Followup Predicts Prognosis in Patients with Prostate Cancer Treated with Combined Androgen BlockadeShuhei Kamada, Shinichi Sakamoto, Keisuke Ando, et al.
Pageof 12